Although ribavirin pharmacogenomics was not investigated in this study, we find it appropriate to discuss an important PGx variant IL28B (IFNL3) rs12979860, implicated in therapeutic response of ribavirin used for treating COVID-19. This evidence concerns the gene IFNL3 and COVID-19.